Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

24.35
Delayed Data
As of May 24
 -0.15 / -0.61%
Today’s Change
11.85
Today|||52-Week Range
24.70
+74.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues23.6M24.1M64.6M4.9M
 
 
 
 
 
Depreciation And Amortization2.1M2.0M3.6M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses59.6M56.7M47.8M51.8M
 
 
 
 
 
Research And Development39.1M37.9M36.1M33.2M
 
 
 
 
 
Total Operating Expenses61.6M58.6M51.4M53.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.1M-34.5M13.2M-49.0M
 
 
 
 
 
Extraordinary Charge0.000.00-600.0K0.00
 
 
Other Expenses57.0K39.0K-101.0K1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.9M-33.2M13.8M-47.6M
 
 
 
 
 
Net Income-36.9M-33.2M13.8M-47.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS73.4M74.6M74.8M75.5M
 
 
 
 
 
Shares To Calculate EPS Diluted73.4M74.6M75.0M75.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.50-$0.44$0.18-$0.63
 
 
 
 
 
EPS Diluted-$0.50-$0.44$0.18-$0.63